Edwards, Genesis to pay $12m in civil penalties for US HSR noncompliance
By Wesley Brown ( July 13, 2026, 20:57 GMT | Insight) -- Edwards Lifesciences and Genesis Medtech will pay $12 million in civil penalties after the US Department of Justice found that the sale of JC Medical to Edwards surpassed the Hart-Scott-Rodino Act threshold for notification. Edwards agreed to purchase JC Medical from Genesis for $115 million, just below the $119.5 million trigger at the time, but an additional $25 million investment into Genesis put the total deal value over the threshold.Edwards Lifesciences and Genesis Medtech will pay $12 million in civil penalties after the US Department of Justice found that the sale of JC Medical to Edwards surpassed the Hart-Scott-Rodino Act threshold for notification....
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.